Increased risk of diabetes for breast cancer survivors

This article originally appeared here.
Share this content:
Increased Risk of Diabetes for Breast Cancer Survivors
Increased Risk of Diabetes for Breast Cancer Survivors

(HealthDay News) -- Postmenopausal women with breast cancer have an increased risk of developing diabetes, which varies over time, according to a study published online Dec. 12 in Diabetologia.

Lorraine L. Lipscombe, M.D., from the Women's College Research Institute in Toronto, and colleagues compared the incidence of diabetes among 24,976 women with breast cancer, aged 55 years and older, and 124,880 age-matched women without breast cancer (control group) using population-based data from Ontario from 1996 to 2008.

The researchers found that, over a mean follow-up of 5.8 years, 9.7 percent of cases and controls developed diabetes. Two years after diagnosis, the risk of diabetes started to increase among breast cancer survivors (hazard ratio [HR], 1.07), and increased further after 10 years (HR, 1.21). In a subgroup of 4,404 women who received adjuvant chemotherapy, the risk peaked in the first two years after breast cancer diagnosis (HR, 1.24) and then decreased.

"In summary, this large, population-based study found a modest increase in the incidence of diabetes among postmenopausal breast cancer survivors compared with women without cancer," the authors write. "However, in patients who received adjuvant chemotherapy, the risk of diabetes was highest early after diagnosis and declined thereafter. The reasons for this relationship are uncertain, and further research is necessary."

Full Text (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs